廣告
香港股市 將在 5 小時 41 分鐘 開市
  • 恒指

    18,015.94
    -277.44 (-1.52%)
     
  • 國指

    6,421.67
    -110.96 (-1.70%)
     
  • 上證綜指

    2,974.01
    +2.72 (+0.09%)
     
  • 道指

    40,183.93
    +183.03 (+0.46%)
     
  • 標普 500

    5,623.98
    +8.63 (+0.15%)
     
  • 納指

    18,438.24
    +39.79 (+0.22%)
     
  • Vix指數

    12.93
    +0.47 (+3.77%)
     
  • 富時100

    8,182.96
    -69.95 (-0.85%)
     
  • 紐約期油

    81.98
    -0.23 (-0.28%)
     
  • 金價

    2,426.60
    +5.90 (+0.24%)
     
  • 美元

    7.8063
    -0.0008 (-0.01%)
     
  • 人民幣

    0.9295
    +0.0014 (+0.15%)
     
  • 日圓

    0.0492
    +0.0000 (+0.02%)
     
  • 歐元

    8.5067
    -0.0087 (-0.10%)
     
  • Bitcoin

    63,498.25
    +3,536.86 (+5.90%)
     
  • CMC Crypto 200

    1,323.84
    +54.89 (+4.35%)
     

Why Labcorp (LH) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why Investors Should Pay Attention to This Value Stock

Different than growth or momentum investors, value-focused investors are all about finding good stocks at good prices, and discovering which companies are trading under what their true value is before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to help pick out the most attractive and discounted stocks.

廣告

Labcorp (LH)

Headquartered in Burlington, NC, Laboratory Corporation of America Holdings or Labcorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. In 2015, Labcorp acquired NJ based Covance, a drug development services company providing a wide range of early stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical and biotechnology industries.

LH sits at a Zacks Rank #3 (Hold), holds a Value Style Score of A, and has a VGM Score of B. Compared to the Medical - Dental Supplies industry's P/E of 18.1X, shares of Labcorp are trading at a forward P/E of 13.9X. LH also has a PEG Ratio of 1.6, a Price/Cash Flow ratio of 10.2X, and a Price/Sales ratio of 1.4X.

Value investors don't just pay attention to a company's valuation ratios; positive earnings play a crucial role, too. Six analysts revised their earnings estimate upwards in the last 60 days for fiscal 2024. The Zacks Consensus Estimate has increased $0.10 to $14.87 per share. LH has an average earnings surprise of 1.4%.

Investors should take the time to consider LH for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Labcorp (LH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research